Total alopecia relateret/ muligvis relateret til administration af topotecan sås hos 9% af patienterne, og udtalt alopecia relateret/ muligvis relateret til administration af topotecan sås hos 11% af patienterne.
Complete alopecia related/ possibly related to topotecan administration was observed in 9% of patients and partial alopecia related/ possibly related to topotecan administration in 11% of patients.